Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan.
AMED
HAV
HIV
current and future research
guideline
Journal
Hepatology research : the official journal of the Japan Society of Hepatology
ISSN: 1386-6346
Titre abrégé: Hepatol Res
Pays: Netherlands
ID NLM: 9711801
Informations de publication
Date de publication:
31 Oct 2023
31 Oct 2023
Historique:
revised:
06
10
2023
received:
27
08
2023
accepted:
23
10
2023
pubmed:
31
10
2023
medline:
31
10
2023
entrez:
31
10
2023
Statut:
aheadofprint
Résumé
In 2018, there was a hepatitis A outbreak in Japan, and hepatitis A virus (HAV) infection is considered a sexually transmitted disease. In general, patients with hepatitis A should be given attention, and this disease should be prevented more than ever. The Japan Agency for Medical Research and Development (AMED) Hepatitis A and E viruses (HAV and HEV) Study Group has worked on the project to create "Recent Advances in Hepatitis A Virus (HAV) Research and Clinical Practice Guidelines for HAV Infection in Japan". The group consists of expert hepatologists and virologists who gathered at virtual meeting on August 5, 2023. Data about the pathogenesis, infection routes, diagnosis, complications, several factors for the severities, vaccination, and current and future treatments for hepatitis A were discussed and debated for a draft version. The participants assessed the quality of cited studies. The finalized recommendations are presented in this review. The recent advances in HAV research and clinical practice for HAV infection in Japan, have been reviewed by the AMED HAV and HEV Study Group.
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP23fk0210132
Organisme : Japan Society for the Promotion of Science (JSPS)
ID : 23K15055
Investigateurs
Mai Totsuka
(M)
Masayuki Honda
(M)
Shuhei Arima
(S)
Ryota Masuzaki
(R)
Naoki Matsumoto
(N)
Masahiro Ogawa
(M)
Hayato Abe
(H)
Shuang Wu
(S)
Naoya Kato
(N)
Jong-Hon Kang
(JH)
Masaharu Takahashi
(M)
Shigeo Nagashima
(S)
Tominari Kobayashi
(T)
Putu Prathiwi Primadharsini
(PP)
Norio Isoda
(N)
Shunji Watanabe
(S)
Hitoshi Mizuo
(H)
Junichi Koyama
(J)
Hitoshi Takagi
(H)
Yuichi Yamazaki
(Y)
Yukihiro Sato
(Y)
Hiroshi Okano
(H)
Tatsunori Nakano
(T)
Manri Kawakami
(M)
Akio Miyasaka
(A)
Tomohiko Koibuchi
(T)
Michiko Koga
(M)
Kazuaki Takahashi
(K)
Takeya Tsutsumi
(T)
Ryuichi Sugiyama
(R)
Mami Matsuda
(M)
Asuka Hirai-Yuki
(A)
Informations de copyright
© 2023 Japan Society of Hepatology.
Références
Yotsuyanagi H, Koike K, Yasuda K, Moriya K, Shintani Y, Fujie H, et al. Prolonged fecal excretion of hepatitis A virus in adult patients with hepatitis A as determined by polymerase chain reaction. Hepatology. 1996;24(1):10-13. https://doi.org/10.1053/jhep.1996.v24.pm0008707246
Fujiwara K, Yokosuka O, Ehata T, Imazeki F, Saisho H, Miki M, et al. Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A. Hepatology. 1997;26(6):1634-1639. https://doi.org/10.1053/jhep.1997.v26.pm0009398009
Migueres M, Lhomme S, Izopet J. Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment. Viruses. 2021;13(10):1900. https://doi.org/10.3390/v13101900
World Health Organization. Hepatitis A. https://www.who.int/news-room/fact-sheets/detail/hepatitis-a#Epidemiology. Accessed 23 June 2023.
Yano K, Tamada Y, Yatsuhashi H, Komori A, Abiru S, Ito K, et al. Dynamic epidemiology of acute viral hepatitis in Japan. Intervirology. 2010;53(1):70-75. https://doi.org/10.1159/000252788
Kiyohara T, Ishii K, Satake M, Matsubayashi K, Suzuki R, Sugiyama R, et al. Seroepidemiology of hepatitis A virus infection in Japan: an area of very low endemicity. Microbiol Immunol. 2023;67(1):14-21. https://doi.org/10.1111/1348-0421.13035
Yan J, Kanda T, Wu S, Imazeki F, Yokosuka O. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatol Res. 2012;42(10):974-981. https://doi.org/10.1111/j.1872-034X.2012.01009.x
Yamamoto C, Ko K, Nagashima S, Harakawa T, Fujii T, Ohisa M, et al. Very low prevalence of anti-HAV in Japan: high potential for future outbreak. Sci Rep. 2019;9(1):1493. https://doi.org/10.1038/s41598-018-37349-1
Lemon SM, Ott JJ, Van Damme P, Shouval D. Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol. 2017;68(1):167-184. [Online ahead of print. https://doi.org/10.1016/j.jhep.2017.08.034
Pintó RM, Pérez-Rodríguez FJ, Costafreda MI, Chavarria-Miró G, Guix S, Ribes E, et al. Pathogenicity and virulence of hepatitis A virus. Virulence. 2021;12(1):1174-1185. https://doi.org/10.1080/21505594.2021.1910442
Wang X, Ren J, Gao Q, Hu Z, Sun Y, Li X, et al. Hepatitis A virus and the origins of picornaviruses. Nature. 2015;517(7532):85-88. https://doi.org/10.1038/nature13806
Cohen JI, Ticehurst JR, Purcell RH, Buckler-White A, Baroudy BM. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol. 1987;61(1):50-59. https://doi.org/10.1128/JVI.61.1.50-59.1987
Fujiwara K, Yokosuka O, Ehata T, Saisho H, Saotome N, Suzuki K, et al. Association between severity of type A hepatitis and nucleotide variations in the 5' non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions. Gut. 2002;51(1):82-88. https://doi.org/10.1136/gut.51.1.82
Gauss-Müller V, Kusov YY. Replication of a hepatitis A virus replicon detected by genetic recombination in vivo. J Gen Virol. 2002;83(Pt 9):2183-2192. https://doi.org/10.1099/0022-1317-83-9-2183
Totsuka A, Moritsugu Y. Hepatitis A virus proteins. Intervirology. 1999;42(2-3):63-68. https://doi.org/10.1159/000024967
Schultz DE, Honda M, Whetter LE, McKnight KL, Lemon SM. Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol. 1996;70(2):1041-1049. https://doi.org/10.1128/JVI.70.2.1041-1049.1996
Kanda T, Yokosuka O, Kato N, Imazeki F, Fujiwara K, Kawai S, et al. Hepatitis A virus VP3 may activate serum response element associated transcription. Scand J Gastroenterol. 2003;38(3):307-313. https://doi.org/10.1080/00365520310000654a
Shukla A, Dey D, Banerjee K, Nain A, Banerjee M. The C-terminal region of the non-structural protein 2B from Hepatitis A Virus demonstrates lipid-specific viroporin-like activity. Sci Rep. 2015;5(1):15884. https://doi.org/10.1038/srep15884
Chen P, Wojdyla JA, Colasanti O, Li Z, Qin B, Wang M, et al. Biochemical and structural characterization of hepatitis A virus 2C reveals an unusual ribonuclease activity on single-stranded RNA. Nucleic Acids Res. 2022;50(16):9470-9489. https://doi.org/10.1093/nar/gkac671
Kanda T, Gauss-Müller V, Cordes S, Tamura R, Okitsu K, Shuang W, et al. Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein. J Viral Hepat. 2010;17(9):618-623. https://doi.org/10.1111/j.1365-2893.2009.01221.x
Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A. 2007;104(17):7253-7258. https://doi.org/10.1073/pnas.0611506104
Qu L, Feng Z, Yamane D, Liang Y, Lanford RE, Li K, et al. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 2011;7(9):e1002169. https://doi.org/10.1371/journal.ppat.1002169
Feng H, Sander AL, Moreira-Soto A, Yamane D, Drexler JF, Lemon SM. Hepatovirus 3ABC proteases and evolution of mitochondrial antiviral signaling protein (MAVS). J Hepatol. 2019;71(1):25-34. https://doi.org/10.1016/j.jhep.2019.02.020
Sun L, Feng H, Misumi I, Shirasaki T, Hensley L, González-López O, et al. Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection. J Hepatol. 2023;78(2):271-280. https://doi.org/10.1016/j.jhep.2022.09.013
Shimizu YK, Shikata T, Beninger PR, Sata M, Setoyama H, Abe H, et al. Detection of hepatitis A antigen in human liver. Infect Immun. 1982;36(1):320-324. https://doi.org/10.1128/iai.36.1.320-324.1982
Mathiesen LR, Møller AM, Purcell RH, London WT, Feinstone SM. Hepatitis A virus in the liver and intestine of marmosets after oral inoculation. Infect Immun. 1980;28(1):45-48. https://doi.org/10.1128/iai.28.1.45-48.1980
Kojima H, Shibayama T, Sato A, Suzuki S, Ichida F, Hamada C. Propagation of human hepatitis A virus in conventional cell lines. J Med Virol. 1981;7(4):273-286. https://doi.org/10.1002/jmv.1890070404
Ashida M, Hara H, Kojima H, Kamimura T, Ichida F, Hamada C. Propagation of hepatitis A virus in hybrid cell lines derived from marmoset liver and Vero cells. J Gen Virol. 1989;70(Pt 9):2487-2494. https://doi.org/10.1099/0022-1317-70-9-2487
Shirasaki T, González-López O, McKnight KL, Xie L, Shiota T, Chen X, et al. Nonlytic quasi-enveloped Hepatovirus release is facilitated by pX protein interaction with the E3 ubiquitin ligase ITCH. J Virol. 2022;96(21):e0119522. https://doi.org/10.1128/jvi.01195-22
Das A, Hirai-Yuki A, González-López O, Rhein B, Moller-Tank S, Brouillette R, et al. TIM1 (HAVCR1) is not essential for cellular entry of either quasi-enveloped or naked hepatitis A virions. mBio. 2017;8(5):e1017. https://doi.org/10.1128/mBio.00969-17
Das A, Rivera-Serrano EE, Yin X, Walker CM, Feng Z, Lemon SM. Cell entry and release of quasi-enveloped human hepatitis viruses. Nat Rev Microbiol. 2023;21(9):1-17. [Online ahead of print]. https://doi.org/10.1038/s41579-023-00889-z
Feng Z, Hensley L, McKnight KL, Hu F, Madden V, Ping L, et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature. 2013;496(7445):367-371. https://doi.org/10.1038/nature12029
Hirai-Yuki A, Hensley L, Whitmire JK, Lemon SM. Biliary secretion of quasi-enveloped human hepatitis A virus. mBio. 2016;7(6):e2016. https://doi.org/10.1128/mBio.01998-16
Kaplan G, Totsuka A, Thompson P, Akatsuka T, Moritsugu Y, Feinstone SM. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 1996;15(16):4282-4296. https://doi.org/10.1002/j.1460-2075.1996.tb00803.x
Ashida M, Hamada C. Molecular cloning of the hepatitis A virus receptor from a simian cell line. J Gen Virol. 1997;78(Pt 7):1565-1569. https://doi.org/10.1099/0022-1317-78-7-1565
Das A, Barrientos R, Shiota T, Madigan V, Misumi I, McKnight KL, et al. Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus. Nat Microbiol. 2020;5(9):1069-1078. https://doi.org/10.1038/s41564-020-0727-8
Ruchusatsawat K, Wongpiyabovorn J, Kawidam C, Thiemsing L, Sangkitporn S, Yoshizaki S, et al. An outbreak of acute hepatitis caused by genotype IB hepatitis A viruses contaminating the water supply in Thailand intervirology. Intervirology. 2016;59(4):197-203. https://doi.org/10.1159/000455856
Bai H, Shiota T, Yoshizaki S, Saito-Obata M, Malbas FF, Jr, Lupisan SP, et al. Detection of subgenotype IA and IIIA hepatitis A viruses in rivers flowing through metro Manila, the Philippines. Jpn J Infect Dis. 2019;72(1):53-55. https://doi.org/10.7883/yoken.JJID.2018.148
Fujiyama S, Akahoshi M, Sagara K, Sato T, Tsurusaki R. An epidemic of hepatitis A related to ingestion of raw oysters. Gastroenterol Jpn. 1985;20(1):6-13. https://doi.org/10.1007/BF02774668
Tominaga A, Kanda T, Akiike T, Komoda H, Ito K, Abe A, et al. Hepatitis A outbreak associated with a revolving sushi bar in Chiba, Japan: application of molecular epidemiology. Hepatol Res. 2012;42(8):828-834. https://doi.org/10.1111/j.1872-034X.2012.00988.x
Viray MA, Hofmeister MG, Johnston DI, Krishnasamy VP, Nichols C, Foster MA, et al. Public health investigation and response to a hepatitis A outbreak from imported scallops consumed raw-Hawaii, 2016. Epidemiol Infect. 2018;147:e28. https://doi.org/10.1017/S0950268818002844
Tsukada R, Ono S, Kobayashi H, Wada Y, Nishizawa K, Fujii M, et al. A cluster of hepatitis A infections presumed to be related to asari clams and investigation of the spread of viral contamination from asari clams. Jpn J Infect Dis. 2019;72(1):44-48. https://doi.org/10.7883/yoken.JJID.2018.279
Ishida T, Nakamura T, Ajisawa A, Negishi M, Kashiyama T, Takechi A, et al. Outbreak of hepatitis A virus infection among HIV-1 seropositive men who had sex with men. Jpn J Infect Dis. 1999;52(3):131-132. https://doi.org/10.7883/yoken.52.131
Kojima T, Tachikawa N, Yosizawa S, Yasuoka C, Yamamoto Y, Genka I, et al. Hepatitis A virus outbreak; a possible indicator of high risk sexual behavior among HIV-1 infected homosexual men. Jpn J Infect Dis. 1999;52(4):173-174. https://doi.org/10.7883/yoken.52.173
Takahashi H, Yotsuyanagi H, Yasuda K, Koibuchi T, Suzuki M, Kato T, et al. Molecular epidemiology of hepatitis A virus in metropolitan areas in Japan. J Gastroenterol. 2006;41(10):981-986. https://doi.org/10.1007/s00535-006-1888-9
da Silva SG, Leon LA, Alves G, Brito SM, Sandes Vde S, Lima MMAF, et al. A rare case of transfusion transmission of hepatitis A virus to two patients with haematological disease. Transfus Med Hemotherapy. 2016;43(2):137-141. https://doi.org/10.1159/000441910
Nara H, Suzuki K, Momma T, Ookawa M, Kawabe H, Yoshida Y, et al. Studies on the outbreak of hepatitis A in an institute for mentally retarded children. Gastroenterol Jpn. 1978;13(5):374-382. https://doi.org/10.1007/BF02776014
Duermeyer W, van der Veen J, Koster B. ELISA in hepatitis A. Lancet. 1978;1(8068):823-824. https://doi.org/10.1016/s0140-6736(78)93023-4
Duermeyer W, van der Veen J. Specific detection of IgM-antibodies by ELISA, applied in hepatitis-A. Lancet. 1978;2(8091):684-685. https://doi.org/10.1016/s0140-6736(78)92802-7
Bower WA, Nainan OV, Han X, Margolis HS. Duration of viremia in hepatitis A virus infection. J Infect Dis. 2000;182(1):12-17. https://doi.org/10.1086/315701
Shin EC, Jeong SH. Natural history, clinical manifestations, and pathogenesis of hepatitis A. Cold Spring Harb Perspect Med. 2018;8(9):a031708. https://doi.org/10.1101/cshperspect.a031708
Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology. 2010;53(1):15-19. https://doi.org/10.1159/000252779
Juniastuti WD, Wahyuddin D, Amin M, Yamani LN, Utsumi T, et al. Analysis of genetic and serology of hepatitis A virus infection during and after outbreak in two junior high schools in Surabaya, Indonesia. J Med Virol. 2019;91(6):1048-1055. https://doi.org/10.1002/jmv.25403
Taniguchi K, Yoshida M, Sunagawa T, Tada Y, Okabe N. Imported infectious diseases and surveillance in Japan. Trav Med Infect Dis. 2008;6(6):349-354. https://doi.org/10.1016/j.tmaid.2008.07.001
Ishii K, Kiyohara T, Yoshizaki S, Wakita T, Shimada T, Nakamura N, et al. Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010. J Clin Virol. 2012;53(3):219-224. https://doi.org/10.1016/j.jcv.2011.11.008
Ishii K, Kiyohara T, Yoshizaki S, Kawabata K, Kanayama A, Yahata Y, et al. Epidemiological and genetic analysis of a 2014 outbreak of hepatitis A in Japan. Vaccine. 2015;33(45):6029-6036. https://doi.org/10.1016/j.vaccine.2015.04.061
National Institute of Infectious Diseases (NIID). Center for surveillance, immunization, and epidemiologic research (CSIER). National surveillance. https://www.niid.go.jp/niid/ja/ydata/11529-report-ja2021-20.html. Accessed on 16 July 2013.
Yoshimura Y, Horiuchi H, Sawaki K, Miyata N, Kumazaki M, Usuku S, et al. Hepatitis A outbreak among men who have sex with men, Yokohama, Japan, January to May 2018. Sex Transm Dis. 2019;46(3):e26-e27. https://doi.org/10.1097/OLQ.0000000000000937
Watanabe S, Morimoto N, Miura K, Takaoka Y, Nomoto H, Tsukui M, et al. Full-genome characterization of the RIVM-HAV16-090-like hepatitis A virus strains recovered from Japanese men who have sex with men, with sporadic acute hepatitis A. Hepatol Res. 2019;49(5):521-530. https://doi.org/10.1111/hepr.13313
Kogiso T, Sagawa T, Oda M, Yoshiko S, Kodama K, Taniai M, et al. Characteristics of acute hepatitis A virus infection before and after 2001: a hospital-based study in Tokyo, Japan. J Gastroenterol Hepatol. 2019;34(10):1836-1842. https://doi.org/10.1111/jgh.14655
Tanaka S, Kishi T, Ishihara A, Watanabe D, Uehira T, Ishida H, et al. Outbreak of hepatitis A linked to European outbreaks among men who have sex with men in Osaka, Japan, from March to July 2018. Hepatol Res. 2019;49(6):705-710. https://doi.org/10.1111/hepr.13314
Koga M, Lim LA, Ogishi M, Satoh H, Kikuchi T, Adachi E, et al. Comparison of the clinical features of hepatitis A in people living with HIV between pandemics in 1999-2000 and 2017-2018 in the metropolitan area of Japan. Jpn J Infect Dis. 2020;73(2):89-95. https://doi.org/10.7883/yoken.JJID.2019.275
Honda M, Asakura H, Kanda T, Somura Y, Ishii T, Yamana Y, et al. Male-dominant hepatitis A outbreak observed among non-HIV-infected persons in the Northern part of Tokyo, Japan. Viruses. 2021;13(2):207. https://doi.org/10.3390/v13020207
Koibuchi T, Koga M, Kikuchi T, Horikomi T, Kawamura Y, Lim LA, et al. Prevalence of hepatitis A immunity and decision-tree analysis among men who have sex with men and are living with human immunodeficiency virus in Tokyo. Clin Infect Dis. 2020;71(3):473-479. https://doi.org/10.1093/cid/ciz843
Baba M, Oka H, Asayama M, Yoshinaga S, Yamashita H, Tachikawa N, et al. Acute hepatitis outbreak in Tokyo caused by hepatitis A virus of common origin transmitted through oral and sexual routes. Jpn J Infect Dis. 2000;53(3):127-129. PMID: 10957712.
Kurata R, Kodama Y, Takamura N, Gomi H. Hepatitis A in a human immunodeficiency virus-infected patient: impending risk during the Tokyo Olympic Games in 2020. J Infect Chemother. 2020;26(9):999-1001. https://doi.org/10.1016/j.jiac.2020.04.010
Mikata R, Yokosuka O, Imazeki F, Fukai K, Kanda T, Saisho H. Prolonged acute hepatitis A mimicking autoimmune hepatitis. World J Gastroenterol. 2005;11(24):3791-3793. https://doi.org/10.3748/wjg.v11.i24.3791
Jung YM, Park SJ, Kim JS, Jang JH, Lee SH, Kim JW, et al. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. J Med Virol. 2010;82(8):1318-1326. https://doi.org/10.1002/jmv.21822
Miura Y, Kanda T, Yasui S, Takahashi K, Haga Y, Sasaki R, et al. Hepatitis A virus genotype IA-infected patient with marked elevation of aspartate aminotransferase levels. Clin J Gastroenterol. 2017;10(1):52-56. https://doi.org/10.1007/s12328-016-0700-5
Yan J, He YS, Song Y, Chen XY, Liu HB, Rao CY. False positive anti-hepatitis A virus immunoglobulin M in autoimmune hepatitis/primary biliary cholangitis overlap syndrome: a case report. World J Clin Cases. 2021;9(22):6464-6468. https://doi.org/10.12998/wjcc.v9.i22.6464
Nagashima S, Ko K, Yamamoto C, Bunthen E, Ouoba S, Chuon C, et al. Prevalence of total hepatitis A antibody among 5 to 7 years old children and their mothers in Cambodia. Sci Rep. 2021;11(1):4778. https://doi.org/10.1038/s41598-021-83710-2
Yotsuyanagi H, Iino S, Koike K, Yasuda K, Hino K, Kurokawa K. Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reaction. J Med Virol. 1993;40(1):35-38. https://doi.org/10.1002/jmv.1890400108
Phan TG, Nguyen TA, Yan H, Okitsu S, Ushijima H. A novel RT-multiplex PCR for enteroviruses, hepatitis A and E viruses and influenza A virus among infants and children with diarrhea in Vietnam. Arch Virol. 2005;150(6):1175-1185. https://doi.org/10.1007/s00705-004-0465-x
Phan TG, Nguyen TA, Yan H, Yagyu F, Kozlov V, Kozlov A, et al. Development of a novel protocol for RT-multiplex PCR to detect diarrheal viruses among infants and children with acute gastroenteritis in Eastern Russia. Clin Lab. 2005;51(7-8):429-435.
Sainokami S, Abe K, Ishikawa K, Suzuki K. Influence of load of hepatitis A virus on disease severity and its relationship with clinical manifestations in patients with hepatitis A. J Gastroenterol Hepatol. 2005;20(8):1165-1175. https://doi.org/10.1111/j.1440-1746.2005.03908.x
Fujiwara K, Kojima H, Yasui S, Okitsu K, Yonemitsu Y, Omata M, et al. Hepatitis A viral load in relation to severity of the infection. J Med Virol. 2011;83(2):201-207. https://doi.org/10.1002/jmv.21958
Ishizaka A, Koga M, Mizutani T, Lim LA, Adachi E, Ikeuchi K, et al. Prolonged gut dysbiosis and fecal excretion of hepatitis A virus in patients infected with human immunodeficiency virus. Viruses. 2021;13(10):2101. https://doi.org/10.3390/v13102101
Wu S, Nakamoto S, Kanda T, Jiang X, Nakamura M, Miyamura T, et al. Ultra-deep sequencing analysis of the hepatitis A virus 5'-untranslated region among cases of the same outbreak from a single source. Int J Med Sci. 2013;11(1):60-64. https://doi.org/10.7150/ijms.7728
Oshiki M, Miura T, Kazama S, Segawa T, Ishii S, Hatamoto M, et al. Microfluidic PCR amplification and MiSeq amplicon sequencing techniques for high-throughput detection and genotyping of human pathogenic RNA viruses in human feces, sewage, and oysters. Front Microbiol. 2018;9:830. https://doi.org/10.3389/fmicb.2018.00830
Persson S, Alm E, Karlsson M, Enkirch T, Norder H, Eriksson R, et al. A new assay for quantitative detection of hepatitis A virus. J Virol Methods. 2021;288:114010. https://doi.org/10.1016/j.jviromet.2020.114010
Lee GY, Park K, Lee YS, Kim JH, Byun KS, Kim J, et al. Molecular diagnosis of patients with hepatitis A virus infection using amplicon-based nanopore sequencing. PLoS One. 2023;18(7):e0288361. https://doi.org/10.1371/journal.pone.0288361
Inoue K, Yoshiba M, Yotsuyanagi H, Otsuka T, Sekiyama K, Fujita R. Chronic hepatitis A with persistent viral replication. J Med Virol. 1996;50(4):322-324. https://doi.org/10.1002/(sici)1096-9071(199612)50:4<322::aid-jmv7>3.0.co;2-a
Heo NY, Lim YS, An J, Ko SY, Oh HB. Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A. Clin Mol Hepatol. 2012;18(4):397-403. https://doi.org/10.3350/cmh.2012.18.4.397
Fujiwara K, Yokosuka O, Imazeki F, Saisho H, Miki M, Omata M. Do high levels of viral replication contribute to fulminant hepatitis A? Liver Int. 2005;25(1):194-195. https://doi.org/10.1111/j.1478-3231.2004.0981.x
Robertson BH, Jansen RW, Khanna B, Totsuka A, Nainan OV, Siegl G, et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol. 1992;73(Pt 6):1365-1377. https://doi.org/10.1099/0022-1317-73-6-1365
Ching KZ, Nakano T, Chapman LE, Demby A, Robertson BH. Genetic characterization of wild-type genotype VII hepatitis A virus. J Gen Virol. 2002;83(Pt 1):53-60. https://doi.org/10.1099/0022-1317-83-1-53
Miyamura T, Ishii K, Kanda T, Tawada A, Sekimoto T, Wu S, et al. Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: recent trend of hepatitis A causing acute liver failure. Hepatol Res. 2012;42(3):248-253. https://doi.org/10.1111/j.1872-034X.2011.00919.x
Yoshida Y, Okada Y, Suzuki A, Kakisaka K, Miyamoto Y, Miyasaka A, et al. Fatal acute hepatic failure in a family infected with the hepatitis A virus subgenotype IB: a case report. Medicine (Baltim). 2017;96(35):e7847. https://doi.org/10.1097/MD.0000000000007847
Endo K, Inoue J, Takahashi M, Mitsui T, Masuko K, Akahane Y, et al. Analysis of the full-length genome of a subgenotype IIIB hepatitis A virus isolate: primers for broadly reactive PCR and genotypic analysis. J Med Virol. 2007;79(1):8-17. https://doi.org/10.1002/jmv.20757
Takahashi Y, Shimizu M. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant Hepatitis. J Gastroenterol Hepatol. 1991;6(2):159-164. https://doi.org/10.1111/j.1440-1746.1991.tb01458.x
Takahashi Y, Okuda K. Fulminant and subfulminant hepatitis in Japan--etiological considerations. Indian J Gastroenterol. 1993;12(Suppl 3):19-21.
Sugawara K, Nakayama N, Mochida S. Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol. 2012;47(8):849-861. https://doi.org/10.1007/s00535-012-0624-x
Mochida S, Nakayama N, Terai S, Yoshiji H, Shimizu M, Ido A, et al. Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan. Hepatol Res. 2022;52(5):417-421. https://doi.org/10.1111/hepr.13763
Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29(3):392-398. https://doi.org/10.1111/j.1478-3231.2008.01887.x
Nakao M, Nakayama N, Uchida Y, Tomiya T, Ido A, Sakaida I, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53(6):752-769. https://doi.org/10.1007/s00535-017-1394-2
Nakao M, Nakayama N, Uchida Y, Tomiya T, Oketani M, Ido A, et al. Deteriorated outcome of recent patients with acute liver failure and late-onset hepatic failure caused by infection with hepatitis A virus: a subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan. Hepatol Res. 2019;49(8):844-852. https://doi.org/10.1111/hepr.13345
Yoo SH, Kim IH, Jang JW, Choi CH, Moon JC, Park JK, et al. Clinical features and risk factors for severe complications among patients with acute hepatitis A virus infection in the Jeonbuk Province of Korea. Korean J Gastroenterol. 2014;63(1):25-31. https://doi.org/10.4166/kjg.2014.63.1.25
Kanda D, Takagi H, Hashimoto Y, Yamazaki Y, Matsui M, Kosone T, et al. Severe manifestation of acute hepatitis A recently found in Gunma, Japan. J Gastroenterol. 2002;37(7):517-522. https://doi.org/10.1007/s005350200080
Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, et al. A model to predict 1-month risk of transplant or death in hepatitis A-related acute liver failure. Hepatology. 2019;70(2):621-629. https://doi.org/10.1002/hep.30262
Hussain Z, Husain SA, Almajhdi FN, Kar P. Immunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A. Virol J. 2011;8(1):254. https://doi.org/10.1186/1743-422X-8-254
Kashyap P, Deka M, Medhi S, Dutta S, Kashyap K, Kumari N. Association of Toll-like receptor 4 with hepatitis A virus infection in Assam. Acta Virol. 2018;62(1):58-62. https://doi.org/10.4149/av_2018_107
Belkaya S, Michailidis E, Korol CB, Kabbani M, Cobat A, Bastard P, et al. Inherited IL-18BP deficiency in human fulminant viral hepatitis. J Exp Med. 2019;216(8):1777-1790. https://doi.org/10.1084/jem.20190669
Zhang L, Yesupriya A, Hu DJ, Chang MH, Dowling NF, Ned RM, et al. Variants in ABCB1, TGFB1, and XRCC1 genes and susceptibility to viral hepatitis A infection in Mexican Americans. Hepatology. 2012;55(4):1008-1018. https://doi.org/10.1002/hep.25513
Kim HY, Eyheramonho MB, Pichavant M, Gonzalez Cambaceres C, Matangkasombut P, Cervio G, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest. 2011;121(3):1111-1118. https://doi.org/10.1172/JCI44182
Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology. 2003;38(3):613-618. https://doi.org/10.1053/jhep.2003.50366
Bose M, Bose S, Saikia A, Medhi S, Deka M. Molecular epidemiology of hepatitis A virus infection in Northeast India. J Med Virol. 2015;87(7):1218-1224. https://doi.org/10.1002/jmv.24168
Yoon YK, Yeon JE, Kim JH, Sim HS, Kim JY, Park DW, et al. Comparative analysis of disease severity between genotypes IA and IIIA of hepatitis A virus. J Med Virol. 2011;83(8):1308-1314. https://doi.org/10.1002/jmv.22139
Kim JH, Yeon JE, Baik SK, Kim YS, Kim HS, Park SH, et al. Genotypic shift of the hepatitis A virus and its clinical impact on acute hepatitis A in Korea: a nationwide multicenter study. Scand J Infect Dis. 2013;45(11):811-818. https://doi.org/10.3109/00365548.2013.805425
Abe K, Shikata T. Fulminant type A viral hepatitis in a chimpanzee. Acta Pathol Jpn. 1982;32(1):143-148. https://doi.org/10.1111/j.1440-1827.1982.tb02035.x
Theamboonlers A, Abe K, Thongmee C, Poovorawan Y. Complete coding sequence and molecular analysis of hepatitis A virus from a chimpanzee with fulminant hepatitis. J Med Primatol. 2012;41(1):11-17. https://doi.org/10.1111/j.1600-0684.2011.00515.x
Collier MG, Khudyakov YE, Selvage D, Adams-Cameron M, Epson E, Cronquist A, et al. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet Infect Dis. 2014;14(10):976-981. https://doi.org/10.1016/S1473-3099(14)70883-7
Ajmera V, Xia G, Vaughan G, Forbi JC, Ganova-Raeva LM, Khudyakov Y, et al. What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepat. 2011;18(7):e167-e174. https://doi.org/10.1111/j.1365-2893.2010.01410.x
Cohen JI, Rosenblum B, Ticehurst JR, Daemer RJ, Feinstone SM, Purcell RH. Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A. 1987;84(8):2497-2501. https://doi.org/10.1073/pnas.84.8.2497
Graff J, Kasang C, Normann A, Pfisterer-Hunt M, Feinstone SM, Flehmig B. Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation. Virology. 1994;204(1):60-68. https://doi.org/10.1006/viro.1994.1510
Zhang H, Chao SF, Ping LH, Grace K, Clarke B, Lemon SM. An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect. Virology. 1995;212(2):686-697. https://doi.org/10.1006/viro.1995.1526
Raychaudhuri G, Govindarajan S, Shapiro M, Purcell RH, Emerson SU. Utilization of chimeras between human (HM-175) and simian (AGM-27) strains of hepatitis A virus to study the molecular basis of virulence. J Virol. 1998;72(9):7467-7475. https://doi.org/10.1128/JVI.72.9.7467-7475.1998
Fujiwara K, Yokosuka O, Ehata T, Imazeki F, Saisho H. PCR-SSCP analysis of 5'-nontranslated region of hepatitis A viral RNA: comparison with clinicopathological features of hepatitis A. Dig Dis Sci. 2000;45(12):2422-2427. https://doi.org/10.1023/a:1005607512633
Fujiwara K, Yokosuka O, Fukai K, Imazeki F, Saisho H, Omata M. Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis. J Hepatol. 2001;35(1):112-119. https://doi.org/10.1016/s0168-8278(01)00074-5
Fujiwara K, Kojima H, Yonemitsu Y, Yasui S, Imazeki F, Miki M, et al. Phylogenetic analysis of hepatitis A virus in sera from patients with hepatitis A of various severities. Liver Int. 2009;29(6):838-845. https://doi.org/10.1111/j.1478-3231.2008.01919.x
Munné MS, Vladimirsky S, Moreiro R, Ciocca M, Cuarterolo M, Otegui L, et al. Molecular characterization of hepatitis A virus in children with fulminant hepatic failure in Argentina. Liver Int. 2008;28(1):47-53. https://doi.org/10.1111/j.1478-3231.2007.01634.x
Kanda T, Jeong SH, Imazeki F, Fujiwara K, Yokosuka O. Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities. PLoS One. 2010;5(12):e15139. https://doi.org/10.1371/journal.pone.0015139
Spada E, Genovese D, Tosti ME, Mariano A, Cuccuini M, Proietti L, et al. An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users. J Hepatol. 2005;43(6):958-964. https://doi.org/10.1016/j.jhep.2005.06.012
Kahraman A, Miller M, Gieseler RK, Gerken G, Scolaro MJ, Canbay A. Non-alcoholic fatty liver disease in HIV-positive patients predisposes for acute-on-chronic liver failure: two cases. Eur J Gastroenterol Hepatol. 2006;18(1):101-105. https://doi.org/10.1097/00042737-200601000-00018
Kanda T, Sasaki R, Masuzaki R, Takahashi H, Mizutani T, Matsumoto N, et al. Co-occurrence of hepatitis A infection and chronic liver disease. Int J Mol Sci. 2020;21(17):6384. https://doi.org/10.3390/ijms21176384
Ida S, Tachikawa N, Nakajima A, Daikoku M, Yano M, Kikuchi Y, et al. Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection. Clin Infect Dis. 2002;34(3):379-385. https://doi.org/10.1086/338152
Maki Y, Kimizuka Y, Sasaki H, Yamamoto T, Hamakawa Y, Tagami Y, et al. Hepatitis A virus-associated fulminant hepatitis with human immunodeficiency virus coinfection. J Infect Chemother. 2020;26(2):282-285. https://doi.org/10.1016/j.jiac.2019.08.010
Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338(5):286-290. https://doi.org/10.1056/NEJM199801293380503
Zhang X, Ke W, Xie J, Zhao Z, Xie D, Gao Z. Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B. Hepatol Int. 2010;4(3):615-620. https://doi.org/10.1007/s12072-010-9204-4
Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol. 1995;90(2):201-205.
Pramoolsinsap C. Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV- or hepatitis C virus-related chronic liver diseases in Thailand. J Viral Hepat. 2000;7(Suppl 1):11-12. https://doi.org/10.1046/j.1365-2893.2000.00017.x
Lefilliatre P, Villeneuve JP. Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health. 2000;91(3):168-170. https://doi.org/10.1007/BF03404264
Hwang YC, Jeong IK, Chon S, Oh S, Ahn KJ, Chung HY, et al. Fulminant Type 1 diabetes mellitus associated with acute hepatitis A. Diabet Med. 2010;27(3):366-367. https://doi.org/10.1111/j.1464-5491.2010.02930.x
Nwe Win N, Kanda T, Nakamura M, Nakamoto S, Okamoto H, Yokosuka O, et al. Free fatty acids or high-concentration glucose enhances hepatitis A virus replication in association with a reduction in glucose-regulated protein 78 expression. Biochem Biophys Res Commun. 2017;483(1):694-699. https://doi.org/10.1016/j.bbrc.2016.12.080
Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine. 1992;10(Suppl 1):S15-S17. https://doi.org/10.1016/0264-410x(92)90533-p
Fouad HM, Reyad EM, El-Din AG. Acute hepatitis A is the chief etiology of acute hepatitis in Egyptian children: a single-center study. Eur J Clin Microbiol Infect Dis. 2018;37(10):1941-1947. https://doi.org/10.1007/s10096-018-3329-0
Gholizadeh O, Akbarzadeh S, Ghazanfari Hashemi M, Gholami M, Amini P, Yekanipour Z, et al. Hepatitis A: viral structure, classification, life cycle, clinical symptoms, diagnosis error, and vaccination. Can J Infect Dis Med Microbiol. 2023;2023:4263309-4263317. https://doi.org/10.1155/2023/4263309
Ertekin V, Selimoğlu MA, Orbak Z. An unusual combination of relapsing and cholestatic hepatitis A in childhood. Yonsei Med J. 2003;44(5):939-942. https://doi.org/10.3349/ymj.2003.44.5.939
Kumar P, Bhatia V. Prolonged cholestasis due to hepatitis A virus infection. Indian Pediatr. 2011;48(6):485-486.
Saboo AR, Vijaykumar R, Save SU, Bavdekar SB. Prolonged cholestasis following hepatitis a virus infection: revisiting the role of steroids. J Global Infect Dis. 2012;4(3):185-186. https://doi.org/10.4103/0974-777X.100588
Alam R, Karim ASMB, Mazumder MW, Das SR, Benzamin M, Sonia ZF, et al. Atypical manifestations of acute viral hepatitis A in children in Bangladesh: are these really uncommon? Indian J Gastroenterol. 2021;40(5):470-476. https://doi.org/10.1007/s12664-021-01200-9
An J, Lee JH, Lee H, Yu E, Lee DB, Shim JH, et al. Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report. Korean J Hepatol. 2012;18(1):84-88. https://doi.org/10.3350/kjhep.2012.18.1.84
Singh SK, Borkar V, Srivastava A, Mathias A, Yachha SK, Poddar U. Need for recognizing atypical manifestations of childhood sporadic acute viral hepatitis warranting differences in management. Eur J Pediatr. 2019;178(1):61-67. https://doi.org/10.1007/s00431-018-3262-3
Coppola N, Genovese D, Pisaturo M, Taffon S, Argentini C, Pasquale G, et al. Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection. Clin Infect Dis. 2007;44(9):e73-e77. https://doi.org/10.1086/513430
Jung YJ, Kim W, Jeong JB, Kim BG, Lee KL, Oh KH, et al. Clinical features of acute renal failure associated with hepatitis A virus infection. J Viral Hepat. 2010;17(9):611-617. https://doi.org/10.1111/j.1365-2893.2009.01216.x
An MW, Yoo JJ, Kim JK, Moon A, Kim SG, Kim YS. Focal segmental glomerulosclerosis followed by acute hepatitis A infection: case report. Medicina (Kaunas). 2023;59(5):819. https://doi.org/10.3390/medicina59050819
Onaga M, Hayashi K, Nishimagi T, Nagata K, Uto H, Kubuki Y, et al. A case of acute hepatitis A with marked hemophagocytosis in bone marrow. Hepatol Res. 2000;17(3):205-211. https://doi.org/10.1016/s1386-6346(99)00076-5
Ishii H, Yamagishi Y, Okamoto S, Saito H, Kikuchi H, Kodama T. Hemophagocytic syndrome associated with fulminant hepatitis A: a case report. Keio J Med. 2003;52(1):38-51.
Tai CM, Liu CJ, Yao M. Successful treatment of acute hepatitis A-associated hemophagocytic syndrome by intravenous immunoglobulin. J Formos Med Assoc. 2005;104(7):507-510.
Koiso H, Kobayashi S, Ueki K, Hamada T, Tsukamoto N, Karasawa M, et al. Pure red cell aplasia accompanied by autoimmune hemolytic anemia in a patient with type A viral hepatitis. Rinsho Ketsueki. 2009;50(5):424-429.
Montgomery CD, Hall EJ, Pellegrino R, Yakes EA, Green JR. Acquired thrombotic thrombocytopenic purpura associated with acute hepatitis A infection. Am J Med. 2021;134(6):e396-e397. https://doi.org/10.1016/j.amjmed.2020.10.045
Bani-Sadr F, Chakvetadze C, Galperine T, Lassel L, Bonnard P, Lependeven C, et al. Biphasic hepatitis A with severe cholestasis and thrombocytopenic purpura in an HIV-1-infected male patient. Med Maladies Infect. 2014;44(2):81-82. https://doi.org/10.1016/j.medmal.2013.12.001
Urganci N, Kilicaslan O, Kalyoncu D, Yilmaz S. Immune thrombocytopenic purpura associated with hepatitis A infection in a five-year old boy: a case report. W Indian Med J. 2014;63(5):536-538. https://doi.org/10.7727/wimj.2013.176
Tanir G, Aydemir C, Tuygun N, Kaya O, Yarali N. Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A. Turk J Gastroenterol. 2005;16(4):217-219.
Al Jandale O, Jumah H, Jamil H. Hepatitis A virus infection is complicated by both pancytopenia and autoimmune hemolytic anemia (AIHA). Ann Med Surg (Lond). 2022;78:103765. https://doi.org/10.1016/j.amsu.2022.103765
Stübgen JP. Neuromuscular complications of hepatitis A virus infection and vaccines. J Neurol Sci. 2011;300(1-2):2-8. https://doi.org/10.1016/j.jns.2010.09.015
Baltadzhiev I, Geneva I, Popivanova N. Guillain-barré syndrome in a child with ongoing viral hepatitis A. Iran J Child Neurol. 2018;12(3):133-138.
Samadi A, Mansour-Ghanaei F, Joukar F, Mavaddati S, Sufi Afshar I. A 30-year-old man with acute motor axonal neuropathy subtype of guillain-barré syndrome having hepatitis A virus infection. Middle East J Dig Dis. 2019;11(2):110-115. https://doi.org/10.15171/mejdd.2018.136
Hao Y, Wang W, Jacobs BC, Qiao B, Chen M, Liu D, et al. Antecedent infections in Guillain-Barré syndrome: a single-center, prospective study. Ann Clin Transl Neurol. 2019;6(12):2510-2517. https://doi.org/10.1002/acn3.50946
Davoudi S, Soudbakhsh A, Emadikouchak H, Nikbakht G, Modabbernia A. Meningoencephalitis associated with hepatitis A infection: a case report and review of literature. Trop Doct. 2010;40(3):176-177. https://doi.org/10.1258/td.2010.090424
Joshi MS, Tandale BV, Gore MM, Bhalla S, Gurav YK, Sapkal GN, et al. Evidence of hepatitis A virus infection in the patients with acute encephalitis syndrome in Gorakhpur region, North India. Acta Virol. 2018;62(2):208-213. https://doi.org/10.4149/av_2018_215
Guillaume M, Mouna L, Coustillères F, Lemée V, Roque-Afonso AM, Mourez T, et al. Invasive meningoencephalitis as the first manifestation of hepatitis A. J Viral Hepat. 2019;26(11):1330-1333. https://doi.org/10.1111/jvh.13177
Park YM, Kang WC, Shin KC, Shin MS, Chung WJ, Cho SJ, et al. Acute viral hepatitis A presented with myopericarditis. Int J Cardiol. 2011;153(2):e34-e36. https://doi.org/10.1016/j.ijcard.2011.02.017
Botero V, García VH, Aristizabal AM, Gomez C, Perez P, Caicedo LA, et al. Hepatitis A, cardiomyopathy, aplastic anemia, and acute liver failure: a devastating scenario. Transpl Infect Dis. 2018;20(2):e12842. https://doi.org/10.1111/tid.12842
Allen O, Edhi A, Hafeez A, Halalau A. A very rare complication of hepatitis A infection: acute myocarditis-A case report with literature review. Case Rep Med. 2018;3625139-3625146. https://doi.org/10.1155/2018/3625139
Azimi A, Shirvani M, Hosseini S, Bazojoo V, Masihpoor N, Mohaghegh S, et al. Acute bilateral granulomatous anterior uveitis as an extra-hepatic manifestation of hepatitis A virus (HAV) infection: a case report. J Ophthalmic Inflamm Infect. 2020;10(1):18. https://doi.org/10.1186/s12348-020-00210-6
Inman RD, Hodge M, Johnston ME, Wright J, Heathcote J. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann Intern Med. 1986;105(5):700-703. https://doi.org/10.7326/0003-4819-105-5-700
Russo RA, Rosenzweig SD, Katsicas MM. Hepatitis A-associated macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: report of 2 cases. J Rheumatol. 2008;35(1):166-168.
Panic N, Mihajlovic S, Vujasinovic M, Bulajic M, Löhr JM. Pancreatitis associated with viral hepatitis: systematic review. J Clin Med. 2020;9(10):3309. https://doi.org/10.3390/jcm9103309
Parry JV, Mortimer PP. The heat sensitivity of hepatitis A virus determined by a simple tissue culture method. J Med Virol. 1984;14(3):277-283. https://doi.org/10.1002/jmv.1890140312
Pascoli F, Pezzuto A, Buratin A, Piovesana A, Fortin A, Arcangeli G, et al. Efficacy of domestic cooking inactivation of human hepatitis A virus in experimentally infected manila clams (Ruditapes philippinarum). J Appl Microbiol. 2016;121(4):1163-1171. https://doi.org/10.1111/jam.13242
Zaaijer HL, Leentvaar-Kuijpers A, Rotman H, Lelie PN. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization. J Med Virol. 1993;40(1):22-27. https://doi.org/10.1002/jmv.1890400106
Taylor-Wiedeman J, Moritsugu Y, Miyamura K, Yamazaki S. Seroepidemiology of hepatitis A virus in Japan. Jpn J Med Sci Biol. 1987;40(3):119-130. https://doi.org/10.7883/yoken1952.40.119
Koga M, Senkoji T, Kubota M, Ishizaka A, Mizutani T, Sedohara A, et al. Predictors associated with a better response to the Japanese aluminum-free hepatitis A vaccine, Aimmugen®, for people living with HIV. Hepatol Res. 2022;52(3):227-234. https://doi.org/10.1111/hepr.13736
Fukushima S, Kiyohara T, Nakano T, Tada Y, Hamada A. Delaying the third dose of Japanese aluminum-free hepatitis A vaccine Aimmugen elicits effective immune responses against hepatitis A in adults. Vaccine. 2023;41(32):4726-4730. https://doi.org/10.1016/j.vaccine.2023.06.048
Mao JS, Chai SA, Xie RY, Chen NL, Jiang Q, Zhu XZ, et al. Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine. 1997;15(9):944-947. https://doi.org/10.1016/s0264-410x(96)00304-0
Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med. 2007;357(17):1685-1694. https://doi.org/10.1056/NEJMoa070546
O'Connor L, McGovern E, O'Meara M, Dean J, Ward M, O'Connor M. Extensive hepatitis A outbreak in an urban childcare facility in Ireland, associated with considerable adult morbidity. Epidemiol Infect. 2018;146(6):705-711. https://doi.org/10.1017/S0950268818000638
Saito R, Imamura A, Nishiura H. Assessing countermeasures during a hepatitis A virus outbreak among men who have sex with men. Theor Biol Med Model. 2021;18(1):19. https://doi.org/10.1186/s12976-021-00150-1
Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, et al. Clinical and molecular characteristics of hepatitis A virus infections during the years 1992-2003 in Ogaki, a centrally located city of Japan. J Clin Virol. 2009;44(2):145-148. https://doi.org/10.1016/j.jcv.2008.12.002
Watanabe S, Isoda N, Ohtake T, Hirosawa T, Morimoto N, Aoki K, et al. Full genome analysis of Philippine indigenous subgenotype IA hepatitis A virus strains from Japanese patients with imported acute hepatitis A. Hepatol Res. 2014;44(3):270-279. https://doi.org/10.1111/hepr.12124
Jeong HW, Kim MK, Yi HJ, Kim DM, Jeon SJ, Lee HK, et al. Hepatitis A virus strains identified in jogaejeot associated with outbreaks in Seoul, South Korea. Lett Appl Microbiol. 2021;73(1):107-112. https://doi.org/10.1111/lam.13482
Bell BP. Hepatitis A vaccine. Semin Pediatr Infect Dis. 2002;13(3):165-173. https://doi.org/10.1053/spid.2002.125859
Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA. 2005;294(2):202-210. https://doi.org/10.1001/jama.294.2.202
Fukushima S, Kiyohara T, Ishii K, Nakano T, Hamada A. Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix®) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen®) for Japanese travelers to endemic countries. Vaccine. 2017;35(47):6412-6415. https://doi.org/10.1016/j.vaccine.2017.10.002
Helmick MJ, Morrow CB, White JH, Bordwine P. Widespread community transmission of hepatitis A virus following an outbreak at a local restaurant - Virginia, September 2021-September 2022. MMWR Morb Mortal Wkly Rep. 2023;72(14):362-365. https://doi.org/10.15585/mmwr.mm7214a2
Seo JY, Choi BY, Ki M, Jang HL, Park HS, Son HJ, et al. Risk factors for acute hepatitis A infection in Korea in 2007 and 2009: a case-control study. J Kor Med Sci. 2013;28(6):908-914. https://doi.org/10.3346/jkms.2013.28.6.908
Vento S. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. J Viral Hepat. 2000;7(Suppl 1):7-8. https://doi.org/10.1046/j.1365-2893.2000.00019.x
Prasoppokakorn T, Vanichanan J, Chaiteerakij R, Jutivorakool K, Udomkarnjananun S, Pongpirul K, et al. A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients. Sci Rep. 2021;11(1):50. https://doi.org/10.1038/s41598-020-80052-3
World Health Organization, HAV. https://www.who.int/news-room/fact-sheets/detail/hepatitis-a. Accessed on 22 July 2023.
Jones JM, Agarwal A, Moorman AC, Hofmeister MG, Hulse JC, Meneveau MO, et al. Donor-derived transmission of hepatitis A virus following kidney transplantation: clinical course of two cases from one donor. Transplant Direct. 2023;9(8):e1506. https://doi.org/10.1097/TXD.0000000000001506
Centers for Disease Control and Prevention (CDC). Foodborne transmission of hepatitis A--Massachusetts, 2001. MMWR Morb Mortal Wkly Rep. 2003;52(24):565-567.
Whelan J, Sonder GJ, Bovée L, Speksnijder A, van den Hoek A. Evaluation of hepatitis A vaccine in post-exposure prophylaxis, The Netherlands, 2004-2012. PLoS One. 2013;8(10):e78914. https://doi.org/10.1371/journal.pone.0078914
Freeman E, Lawrence G, McAnulty J, Tobin S, MacIntyre CR, Torvaldsen S. Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines. Vaccine. 2014;32(42):5509-5513. https://doi.org/10.1016/j.vaccine.2014.07.048
Parrón I, Planas C, Godoy P, Manzanares-Laya S, Martínez A, Sala MR, et al. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis. Hum Vaccin Immunother. 2017;13(2):423-427. https://doi.org/10.1080/21645515.2017.1264798
Haddix M, Civen R, Hacker JK, Probert W, New S, Green N, et al. Use of molecular epidemiology to inform response to a hepatitis A outbreak - Los Angeles county, California, October 2018-April 2019. MMWR Morb Mortal Wkly Rep. 2020;69(26):820-824. https://doi.org/10.15585/mmwr.mm6926a3
Bohm SR, Berger KW, Hackert PB, Renas R, Brunette S, Parker N, et al. Hepatitis A outbreak among adults with developmental disabilities in group homes--Michigan, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(6):148-152. PMID: 25695320.
Yoshimura Y, Horiuchi H, Miyata N, Kondo M, Tachikawa N. Hepatitis A virus infection in an HIV-positive man with previously confirmed immunity against hepatitis A virus. Clin J Gastroenterol. 2020;13(5):844-846. https://doi.org/10.1007/s12328-020-01102-x
Watson JC, Fleming DW, Borella AJ, Olcott ES, Conrad RE, Baron RC. Vertical transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit. J Infect Dis. 1993;167(3):567-571. https://doi.org/10.1093/infdis/167.3.567
Urganci N, Arapoglu M, Akyildiz B, Nuhoğlu A. Neonatal cholestasis resulting from vertical transmission of hepatitis A infection. Pediatr Infect Dis J. 2003;22(4):381-382. https://doi.org/10.1097/00006454-200304000-00023
Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130(4):1129-1134. https://doi.org/10.1053/j.gastro.2006.01.007
Terrault NA, Levy MT, Cheung KW, Jourdain G. Viral hepatitis and pregnancy. Nat Rev Gastroenterol Hepatol. 2021;18(2):117-130. https://doi.org/10.1038/s41575-020-00361-w
Fujiwara K, Yasui S, Yonemitsu Y, Mikata R, Arai M, Kanda T, et al. Efficacy of high-dose corticosteroid in the early stage of viral acute liver failure. Hepatol Res. 2014;44(5):491-501. https://doi.org/10.1111/hepr.12148
Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20(11):1169-1172. https://doi.org/10.1111/j.1525-1594.1996.tb00657.x
Fujiwara K, Abe R, Yasui S, Yokosuka O, Kato N, Oda S. High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis. Hepatol Res. 2019;49(2):224-231. https://doi.org/10.1111/hepr.13255
Nakada TA, Oda S, Abe R, Hattori N. Changes in acute blood purification therapy in critical care: republication of the article published in the Japanese Journal of Artificial Organs. J Artif Organs. 2020;23(1):14-18. https://doi.org/10.1007/s10047-019-01113-7
Uemoto S, Inomata Y, Sakurai T, Egawa H, Fujita S, Kiuchi T, et al. Living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;70(1):152-157. PMID: 10919593.
Sato S, Suzuki K, Takikawa Y, Endo R, Omata M, Japanese National Study Group of Fulminant Hepatitis. Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey. Hepatol Res. 2004;30(3):155-161. https://doi.org/10.1016/j.hepres.2004.08.003
Hayashi M, Shimizu T, Tsunematsu I, Hirokawa F, Asakuma M, Takeshita A, et al. Hepatitis A virus-related late-onset hepatic failure: a case report. Exp Clin Transplant. 2011;9(2):150-152.
Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, et al. Outcome of patients with acute liver failure awaiting liver transplantation in Japan. Hepatol Res. 2020;50(10):1186-1195. https://doi.org/10.1111/hepr.13549
Shingina A, Mukhtar N, Wakim-Fleming J, Alqahtani S, Wong RJ, Limketkai BN, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023;118(7):1128-1153. https://doi.org/10.14309/ajg.0000000000002340
Yoshiba M, Inoue K, Sekiyama K. Interferon for hepatitis A. Lancet. 1994;343(8892):288-289. https://doi.org/10.1016/s0140-6736(94)91132-0
Chaudhary RK, Andonov AP. Effect of ribavirin on hepatitis A virus replication in vitro. Can J Infect Dis. 1992;3(2):67-70. https://doi.org/10.1155/1992/531837
Jiang W, Muhammad F, Ma P, Liu X, Long G. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system. Antivir Res. 2018;154:51-57. https://doi.org/10.1016/j.antiviral.2018.04.007
Sasaki-Tanaka R, Shibata T, Okamoto H, Moriyama M, Kanda T. Favipiravir inhibits hepatitis A virus infection in human hepatocytes. Int J Mol Sci. 2022;23(5):2631. https://doi.org/10.3390/ijms23052631
Kanda T, Yokosuka O, Imazeki F, Fujiwara K, Nagao K, Saisho H. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells. Biochem Biophys Res Commun. 2005;331(2):621-629. https://doi.org/10.1016/j.bbrc.2005.03.212
Yang L, Kiyohara T, Kanda T, Imazeki F, Fujiwara K, Gauss-Müller V, et al. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha. Virol J. 2010;7(1):212. https://doi.org/10.1186/1743-422X-7-212
Kanda T, Imazeki F, Nakamoto S, Okitsu K, Fujiwara K, Yokosuka O. Internal ribosomal entry-site activities of clinical isolate-derived hepatitis A virus and inhibitory effects of amantadine. Hepatol Res. 2010;40(4):415-423. https://doi.org/10.1111/j.1872-034X.2010.00617.x
Sasaki-Tanaka R, Shibata T, Moriyama M, Okamoto H, Kogure H, Kanda T. Amantadine and rimantadine inhibit hepatitis A virus replication through the induction of autophagy. J Virol. 2022;96(18):e0064622. https://doi.org/10.1128/jvi.00646-22
Kanda T, Nakamoto S, Wu S, Nakamura M, Jiang X, Haga Y, et al. Direct-acting antivirals and host-targeting agents against the hepatitis A virus. J Clin Transl Hepatol. 2015;3(3):205-210. https://doi.org/10.14218/JCTH.2015.00016
Kanda T, Sasaki-Tanaka R, Masuzaki R, Matsumoto N, Okamoto H, Moriyama M. Knockdown of mitogen-activated protein kinase kinase 3 negatively regulates hepatitis A virus replication. Int J Mol Sci. 2021;22(14):7420. https://doi.org/10.3390/ijms22147420
Sasaki-Tanaka R, Nagulapalli Venkata KC, Okamoto H, Moriyama M, Kanda T. Evaluation of potential anti-hepatitis A virus 3C protease inhibitors using molecular docking. Int J Mol Sci. 2022;23(11):6044. https://doi.org/10.3390/ijms23116044
Sasaki-Tanaka R, Masuzaki R, Okamoto H, Shibata T, Moriyama M, Kogure H, et al. Drug screening for hepatitis A virus (HAV): nicotinamide inhibits c-Jun expression and HAV replication. J Virol. 2023;97(2):e0198722. https://doi.org/10.1128/jvi.01987-22
Sasaki-Tanaka R, Shibata T, Moriyama M, Kogure H, Hirai-Yuki A, Okamoto H, et al. Masitinib inhibits hepatitis A virus replication. Int J Mol Sci. 2023;24(11):9708. https://doi.org/10.3390/ijms24119708
Kanda T, Zhang B, Kusov Y, Yokosuka O, Gauss-Müller V. Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site. Biochem Biophys Res Commun. 2005;330(4):1217-1223. https://doi.org/10.1016/j.bbrc.2005.03.105
Kanda T, Kusov Y, Yokosuka O, Gauss-Müller V. Interference of hepatitis A virus replication by small interfering RNAs. Biochem Biophys Res Commun. 2004;318(2):341-345. https://doi.org/10.1016/j.bbrc.2004.03.194
Kusov Y, Kanda T, Palmenberg A, Sgro JY, Gauss-Müller V. Silencing of hepatitis A virus infection by small interfering RNAs. J Virol. 2006;80(11):5599-5610. https://doi.org/10.1128/JVI.01773-05
Qu L, Lemon SM. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses. Semin Liver Dis. 2010;30(4):319-332. https://doi.org/10.1055/s-0030-1267534
Kanda T, Wu S, Kiyohara T, Nakamoto S, Jiang X, Miyamura T, et al. Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation. Viral Immunol. 2012;25(5):379-386. https://doi.org/10.1089/vim.2012.0021
Kanda T, Sasaki R, Masuzaki R, Takahashi H, Fujisawa M, Matsumoto N, et al. Additive effects of zinc chloride on the suppression of hepatitis A virus replication by interferon in human hepatoma Huh7 cells. Vivo. 2020;34(6):3301-3308. https://doi.org/10.21873/invivo.12168
Misumi I, Li Z, Sun L, Das A, Shiota T, Cullen J, et al. Iminosugar glucosidase inhibitors reduce hepatic inflammation in hepatitis A virus-infected Ifnar1-/- mice. J Virol. 2021;95(11):e0005821. https://doi.org/10.1128/JVI.00058-21
Sun L, Li Y, Misumi I, González-López O, Hensley L, Cullen JM, et al. IRF3-mediated pathogenicity in a murine model of human hepatitis A. PLoS Pathog. 2021;17(9):e1009960. https://doi.org/10.1371/journal.ppat.1009960
Shiota T, Matsuda M, Zheng X, Nagata N, Ishii K, Suzuki R, et al. Macrophage depletion reactivates fecal virus shedding following resolution of acute hepatitis A in Ifnar1-/- mice. J Virol. 2022;96(23):e0149622. https://doi.org/10.1128/jvi.01496-22
Klinger MH, Kämmerer R, Hornei B, Gauss-Müller V. Perinuclear accumulation of hepatitis A virus proteins, RNA, and particles and ultrastructural alterations in infected cells. Arch Virol. 2001;146(12):2291-2307. https://doi.org/10.1007/s007050170003
Jiang X, Kanda T, Haga Y, Sasaki R, Nakamura M, Wu S, et al. Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication. Exp Ther Med. 2017;13(6):3305-3308. https://doi.org/10.3892/etm.2017.4407
Win NN, Kanda T, Nakamoto S, Moriyama M, Jiang X, Suganami A, et al. Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression. Int J Med Sci. 2018;15(11):1153-1159. https://doi.org/10.7150/ijms.27489
Pharmaceuticals and Medical Devices Agency. Aimmugen. https://www.info.pmda.go.jp/go/pack/631340GD1030_4_03/?view=frame&style=XML&lang=ja. Accessed October 1, 2023 (available in Japanese).
Maki Y, Edo N, Mizuguchi M, Ikeda M, Kitano M, Kitagami E, et al. Impact of frequency and duration of freeze-dried inactivated tissue culture hepatitis A vaccine (Aimmugen®) vaccination on antibody titers; a Japanese cross-sectional study. Vaccine. 2023;41(41):5974-5978. https://doi.org/10.1016/j.vaccine.2023.08.030